How India's Gynae & Infertility Pharma Exports Are Growing in China?

India is known as the Pharmacy of the World because it supplies affordable medicines to many countries. Indian pharmaceutical companies provide generic medicines to more than 200 countries around the world. India is also one of the leading pharmaceutical industries, ranking 3rd in terms of production volume and 11th by value.

With the growing global demand for Indian pharmaceutical medicines, the demand for India's gynae and infertility products in China is also witnessing significant growth. China is facing growing concerns about infertility and declining birth rates. As the need for reproductive healthcare increases, the demand for India's gynae and infertility products in China is also growing. This is creating new opportunities for Indian pharmaceutical companies to expand their business in the Chinese market. Starting a gynaecology pharma company in India can be very beneficial, as the demand for India's gynae and infertility products in China continues to grow in the international market.

How India's Gynae & Infertility Pharma Exports Are Growing in China? 

China's infertility crisis and declining birth rates are increasing the demand for India's gynae and infertility products in China. India exports high-quality and affordable pharmaceutical products all around the globe. One of the key developments was China’s removal of the 30% import duty on Indian medicines. This gave Indian generic drug manufacturers easier access to the Chinese market and also reduced the overall cost of imported gynae medicines. As a result, Indian gynae products became more competitive and attractive to the buyers in China.

Growing demand for India's gynae and infertility products in China

China once had one of the largest populations in the world, but now its population is facing some major challenges. China’s birth rate has dropped from 10.41 births per 1,000 people in 2019 to 6.39 in 2023. This decline and growing concerns about infertility are increasing the demand for India's gynae and infertility products in China. China’s fertility services market was valued at approximately USD 2.58 billion in 2024 and is expected to reach USD 9.15 billion by 2034, growing at a CAGR of 12.2%.

Challenges for Indian Gynae Pharma Exporters in China 

Indian pharmaceutical companies also face some challenges while exporting Gynae Pharma products in China. 

  • Local market preference: Most of the users prefer local pharmaceutical companies for gynae and infertility products over imported brands. China’s preference for domestic manufacturers and locally sourced medicines makes it difficult for Indian pharmaceutical products to gain a strong position in the market.

  • Steep Price Competition: Chinese generic drug manufacturers often offer medicines at highly competitive prices, making it difficult for imported Indian gynaecology products to compete on cost.

Future Opportunities for Indian Gynae & Infertility Pharma Exports

The future demand for India's gynae and infertility products in China is expected to grow, creating good opportunities for the industry in the coming years. 

  • Rising infertility rates: Rising infertility rates play a crucial role in the high demand for gynae and infertility products all over the globe. The global fertility market was valued at approximately USD 39.27 billion in 2025 and is projected to reach around USD 92.60 billion by 2035.

  • Cost-efficient manufacturing: The Indian Pharmaceutical market is known for its affordability. India provides high-quality products at a very low cost due to cheap labour.

  • Complex Generics and Biosimilars: Shifting from basic generic medicines to advanced biosimilars for reproductive healthcare can help pharmaceutical companies enter regulated international markets and achieve better profit margins.

Conclusion

With increasing fertility rates, the demand for India's gynae and infertility products in China is also increasing. The Chinese fertility service market is growing at a CAGR of 12.2%. However, entering and growing in the Chinese market is quite challenging. To succeed in the global market, Indian pharmaceutical companies need to focus on product quality, competitive pricing and shift to advanced biosimilars. With the growing demand for India’s gynae and infertility products in China, Indian pharmaceutical companies have promising opportunities to expand their presence in the Chinese reproductive healthcare market. 

Comments

Post a Comment

Popular posts from this blog

How Adorefem is Revolutionizing Fertility Product Exports

  How Adorefem is Revolutionizing Fertility Product Exports - Infertility, a concern that is causing serious disturbances in the lives of both men and women. Not only the changing lifestyle or unbalanced diet can be blamed, but many physiological factors, such as stress, alcoholic consumption, hormonal imbalance, etc., also play a major role in developing this health concern.  Currently, the world has recorded that approximately 17% of couples are dealing with infertility issues, thereby increasing its market size to a new level. Therefore, many gynecology companies in India have taken great initiatives to bring a change in the infertility cases.  Adorefem, a trusted Infertility Supplements Exporter from India , has a wide range of products manufactured with the latest technologies to yield result-driven solutions. Our company believes in reducing the reproductive health issues in the world, therefore adhering to cutting-edge approaches that can lead to revolutionizing th...
Read more

How Adorefem Ensures Competitive Pricing Without Compromising Quality

How Adorefem Ensures Competitive Pricing Without Compromising Quality— The Pharmaceutical Industry has great potential for a successful business. However, to ensure this, there are certain things that the entrepreneur has to look such as quality, affordability, beneficial location, etc.  The rapidly changing demands and rising health concerns can affect the pharma market and businesses. So, if you have something unique to offer, like budget-friendly medicines, then in this ever-growing pharmaceutical market, you can soar high in the long run. With reasonable pricing, assuring that you are marketing premium products is also necessary as anything.  Adorefem, a leading Gynaecology Company in India , deals in high-quality medicines at reasonable prices. They manufacture infertility and other women's health products with stringent quality measures so that the partners can get desired results.  Our company will provide a close closure to such strategies that can help you choose...
Read more

How to Launch Your Nutraceutical Business with Coral Calcium + D3 Products

How to Launch Your Nutraceutical Business with Coral Calcium + Vitamin D3 Products - The nutritional supplement market is growing at a rapid pace. This market has shot up more after the pandemic, when people have become aware of their health and the benefits of health-enhancing medications. Its prevalence is higher in the case of women as during pregnancy, in case of heavy menstrual bleeding, in the menopausal stage, and many more phases, their nutritional health gets imbalanced. In this, the supplements named Coral Calcium and Vitamin D3 play an effective role, and it is profitable too from a marketing point of view.  Adorefem, being a trusted gynecology medicine company backed by a stronghold in nutraceuticals, can help you dive into this business and start getting higher returns, along with establishing your brand. This will not only place you in the booming nutraceutical market but also give you a strong presence in the ever-growing gynecology market.  Whether you are a ...
Read more